| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000039020 |
| Receipt No. | R000044489 |
| Scientific Title | Development of screening method for detecting and preventing advanced kidney diseases |
| Date of disclosure of the study information | 2020/01/06 |
| Last modified on | 2021/06/28 (Ver. 4) |
| Basic information | ||
| Public title | Development of screening method for detecting and preventing advanced kidney diseases | |
| Acronym | K-SCREAM | |
| Scientific Title | Development of screening method for detecting and preventing advanced kidney diseases | |
| Scientific Title:Acronym | K-SCREAM | |
| Region |
|
|
| Condition | ||||
| Condition | advanced kidney disease | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | Establish an accurate method for detecting advanced kidney disease from subject with serum creatinine measurements and/or urinalyses in undeserved medical area. |
| Basic objectives2 | Others |
| Basic objectives -Others | Comparing accuracy for detecting kidney disease between systemic searching by utilizing medical records and practical consultation to nephrologists. |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Kidney disease determined by elevated serum creatinine and positive proteinuria |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Subjects with serum creatinine measurements and/or urinalyses in our institute | |||
| Key exclusion criteria | Subjects with intention of opt-out | |||
| Target sample size | 8000 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kamisu Saiseikai Hospital | ||||||
| Division name | Nephrology, Internal medicine | ||||||
| Zip code | 314-0112 | ||||||
| Address | 7-2-45 Shitte Chuo, Kamisu city, Ibaraki | ||||||
| TEL | 0299-97-2111 | ||||||
| knagai@md.tsukuba.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kamisu Saiseikai Hospital | ||||||
| Division name | Nephrology, Internal medicine | ||||||
| Zip code | 314-0112 | ||||||
| Address | 7-2-45 Shitte Chuo, Kamisu city, Ibaraki | ||||||
| TEL | 0299-97-2111 | ||||||
| Homepage URL | |||||||
| knagai@md.tsukuba.ac.jp | |||||||
| Sponsor | |
| Institute | Saiseikai |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Undetermined |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Kamisu Saiseikai |
| Address | 7-2-45 Shitte Chuo, Kamisu city, Ibaraki |
| Tel | 0299-97-2111 |
| knagai@md.tsukuba.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | https://onlinelibrary.wiley.com/doi/10.1002/jgf2.375 |
| Publication of results | Published |
| Result | |||||||
| URL related to results and publications | https://onlinelibrary.wiley.com/doi/10.1002/jgf2.375 | ||||||
| Number of participants that the trial has enrolled | 20000 | ||||||
| Results | https://onlinelibrary.wiley.com/doi/10.1002/jgf2.375 | ||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | https://onlinelibrary.wiley.com/doi/10.1002/jgf2.375 | ||||||
| Participant flow | https://onlinelibrary.wiley.com/doi/10.1002/jgf2.375 | ||||||
| Adverse events | https://onlinelibrary.wiley.com/doi/10.1002/jgf2.375 | ||||||
| Outcome measures | https://onlinelibrary.wiley.com/doi/10.1002/jgf2.375 | ||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | No applicable |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000044489 |